ASBP
Aspire Biopharma Holdings Inc
$
0.399
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.4191
Open
0.378
VWAP
0.40
Vol
690.27K
Mkt Cap
19.76M
Low
0.3602
Amount
274.18K
EV/EBITDA(TTM)
--
Total Shares
49.53M
EV
23.25M
EV/OCF(TTM)
--
P/S(TTM)
--
Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. It develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. It has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. It also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
Show More
Valuation Metrics
The current forward P/E ratio for Aspire Biopharma Holdings Inc (ASBP.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Aspire Biopharma Holdings Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2025Q1
YoY :
+516.67%
-15.56M
Operating Profit
FY2025Q1
YoY :
+546.16%
-15.94M
Net Income after Tax
FY2025Q1
YoY :
+55.56%
-0.42
EPS - Diluted
FY2025Q1
N/A
Free Cash Flow
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
1
520.0K
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ASBP News & Events
Events Timeline
2025-08-13 (ET)
2025-08-13
09:16:40
Aspire Biopharma launches BUZZ BOMB at FitCon, FitExpo
2025-07-30 (ET)
2025-07-30
19:46:43
Aspire Biopharma announces CEO transition
2025-07-09 (ET)
2025-07-09
08:45:59
Aspire Biopharma announces 'positive' consumer feedback on Buzz Bomb
Sign Up For More Events
Sign Up For More Events
News
2.0
05-20BenzingaWhy Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
1.0
04-15GlobenewswirePresenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
3.5
03-13Business InsiderAspire Biopharma provides update on recently filed U.S. patent applications
Sign Up For More News
People Also Watch
MSFT
Microsoft Corp
520.580
USD
-1.64%
WMT
Walmart Inc
100.990
USD
-2.54%
AVGO
Broadcom Inc
309.090
USD
-1.20%
AMZN
Amazon.com Inc
224.560
USD
+1.40%
NVDA
NVIDIA Corp
181.590
USD
-0.86%
TSLA
Tesla Inc
339.380
USD
-0.43%
XOM
Exxon Mobil Corp
107.600
USD
+1.39%
AAPL
Apple Inc
233.330
USD
+1.60%
ORCL
Oracle Corp
244.180
USD
-3.81%
META
Meta Platforms Inc
780.080
USD
-1.26%
FAQ
What is Aspire Biopharma Holdings Inc (ASBP) stock price today?
The current price of ASBP is 0.399 USD — it has increased 10.83 % in the last trading day.
What is Aspire Biopharma Holdings Inc (ASBP)'s business?
What is the price predicton of ASBP Stock?
What is Aspire Biopharma Holdings Inc (ASBP)'s revenue for the last quarter?
What is Aspire Biopharma Holdings Inc (ASBP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Aspire Biopharma Holdings Inc (ASBP)'s fundamentals?
How many employees does Aspire Biopharma Holdings Inc (ASBP). have?